Subscribe to RSS - ResMed


ResMed, Invacare report earnings


SAN DIEGO and ELYRIA, Ohio – Recently released earnings from ResMed and Invacare are a mixed bag, with the former posting small gains and the latter stumbling.

Trial closes for 3B Medical, ResMed


LAKE WALES, Fla. – The trial between 3B Medical/BMC Medical and ResMed concluded on April 17, but a final decision is not expected until December, according to a press release.

ResMed snags two design awards


SAN DIEGO – ResMed has won two Red Dot Product Design Awards for 2014—one for its AirFit P10 nasal pillows mask and one for its soon-to-be-launched Astral 150 life support ventilator. ResMed was also recognized in 2010 for its S9 Series.

In brief: ICD-10 delay is final, patent case nears trial


WASHINGTON – President Obama has signed a “doc fix” bill that delays ICD-10 implementation for at least one year, until Oct. 1, 2015.

Patent case nears trial


SAN DIEGO – Just ahead of a trial, ResMed has dropped one of its patent infringement claims against BMC Medical/3B Medical, according to BMC/3B Medical.

ResMed rebrands


SAN DIEGO – A new tagline, “changing lives with every breath,” accompanies ResMed’s updated logo, symbolizing the oxygenation of blood.

In brief: Leadership changes at Invacare, layoffs at All-States


ELYRIA, Ohio – Lou Slangen, Invacare’s executive vice president and chief product officer, will retire at the end of February after 27 years with the company, according to a Feb. 27 release.

Gov’t agrees to re-examine ResMed patents


SAN DIEGO – The U.S. Patent and Trademark Office has agreed to re-examine five ResMed patents in response to challenges filed by Apex Medical, the manufacturer has announced.

ResMed founder named to CONNECT Hall of Fame


SAN DIEGO – ResMed Founder Peter Farrell has been inducted into the CONNECT Entrepreneur Hall of Fame for his work in sleep and respiratory medicine, the company announced Feb. 19.

Patent tug-of-war continues


SAN DIEGO – Apex Medical has initiated challenges to four ResMed patents, it announced today. Apex has initiated challenges in the European Patent Office, the German Federal Patent Court, and the German Patent and Trade Mark Office.